Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8215814 | 0.88 | CYP1A2 (0.37) | CYP2C9 | |
| SCHEMBL8218322 | 0.79 | TLR4 (0.36) | TLR4CYP2C9 | |
| SCHEMBL8215928 | 0.77 | TLR4 (0.40) | TLR4CYP2C9 | |
| SCHEMBL5836344 | 0.77 | TLR4 (0.42) | TLR4CYP2C9 | |
| SCHEMBL5836340 | 0.77 | TLR4 (0.42) | TLR4CYP2C9 | |
| SCHEMBL6697654 | 0.77 | TLR4 (0.42) | TLR4CYP2C9 | |
| SCHEMBL22072009 | 0.75 | — | — | |
| SCHEMBL8217513 | 0.75 | TLR4 (0.41) | TLR4CYP2C9 | |
| SCHEMBL11019067 | 0.75 | TLR4 (0.41) | TLR4CYP2C9 | |
| SCHEMBL11019071 | 0.75 | TLR4 (0.41) | TLR4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6143198-A | SUITABLE FOR USE AS ELECTRO-OPTICAL DISPLAY MATERIALS; LIQUID CRYSTALLINE COMPOUND HAVING A LARGE ELASTIC CONSTANT RATIO, EXCELLENT COMPATIBILITY WITH OTHER LIQUID CRYSTALLINE COMPOUND, AND LOW TEMPERATURE CHEMICAL STABILITY | CHISSO CORPORATION (JP) | 2000-11-07 | — | — | US | disclosed |
| EP-0828700-A1 | LIQUID CRYSTALLINE COMPOUNDS HAVING EXO-METHYLENE SITE AND LIQUID CRYSTAL COMPOSITIONS COMPRISING THE SAME | CHISSO CORPORATION (JP) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996037451-A1 | LIQUID CRYSTALLINE COMPOUNDS HAVING EXO-METHYLENE SITE AND LIQUID CRYSTAL COMPOSITIONS COMPRISING THE SAME | CHISSO CORPORATION (JP) | 1996-11-28 | — | — | WO | disclosed |